Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian stock markets trade above the dotted line
Tue, 14 Feb 01:30 pm

Indian stock market indices continue to trade above the dotted line over the last two hours of trade. Realty and Auto stocks witnessed maximum buying interest while Pharma and Power stocks witnessed maximum selling pressure.

The BSE-Sensex is up by 29 points, while the NSE-Nifty is up by 13 point. BSE Mid cap index and the BSE Small cap index are up by 0.65% and 0.63% respectively. The rupee is trading at 49.28 to the US dollar.

Stocks in the Energy sector are trading mixed with Essar Oil and Gujarat State Petronet Ltd. leading the gainers and Mangalore Refineries and Petrochemicals Ltd.(MRPL) and Oil and Natural Gas Ltd. (ONGC) trading the weakest. Castrol India Ltd. has reported results for the fourth quarter of calendar year 2011(4QCY11). The growth in the topline came at 10.7% YoY during the quarter. The company was able to achieve this growth despite a decline in demand mainly due to pro active pricing moves throughout the year. The operating profits for the quarter declined slightly by 0.4% YoY, with margins at 20.2% (versus 22.5% last year). For CY11, the decline was more prominent at 8.6% YoY with margins at 22.4% versus 26.7% last year. This was mainly on account of increase in the cost of base oil and additives. The net profits for the quarter gained 0.8% YoY with margins at 13.8% (versus 15.2% last year).For CY11, the bottomline declined by 1.9% YoY with margins at 16.1% (versus 17.9% last year). The stock was trading in the green.

Essel Propack has declared its December 2011 results. Consolidated sales of the company increased by 13.7% YoY backed by 18% growth in its India operations and double-digit growth recorded by each of the four overseas markets. However higher raw material expenses kept margins under pressure at around 16.2%. At the net level, profits tumbled by 12.9% on account of large foreign exchange loss of Rs 5.2 m as compared to a gain of Rs 59.7 m in the year-ago quarter. Earnings from its Indian operations fell by 5% on account of high input prices, weak rupee and steep rise in interest rates.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets trade above the dotted line". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.